ONCOINVENT

Summary

Oncoinvent is a Norwegian, clinical-stage radiopharmaceutical company that develops direct alpha therapy for solid cancers.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 12 M

Avg. Deal Size£ 12 M

Market Context

Senior Management